156 related articles for article (PubMed ID: 36600115)
1. Pleomorphic giant cell carcinoma of the prostate: clinicopathologic analysis and oncological outcomes.
Bilé-Silva A; Lopez-Beltran A; Rasteiro H; Vau N; Blanca A; Gomez E; Gaspar F; Cheng L
Virchows Arch; 2023 Mar; 482(3):493-505. PubMed ID: 36600115
[TBL] [Abstract][Full Text] [Related]
2. Prostatic Adenocarcinoma With Focal Pleomorphic Giant Cell Features: A Series of 30 Cases.
Alharbi AM; De Marzo AM; Hicks JL; Lotan TL; Epstein JI
Am J Surg Pathol; 2018 Oct; 42(10):1286-1296. PubMed ID: 29944471
[TBL] [Abstract][Full Text] [Related]
3. Pleomorphic giant cell carcinoma of prostate: Rare tumor with unique clinicopathological, immunohistochemical, and molecular features.
El-Zaatari ZM; Thomas JS; Divatia MK; Shen SS; Ayala AG; Monroig-Bosque P; Shehabeldin A; Ro JY
Ann Diagn Pathol; 2021 Jun; 52():151719. PubMed ID: 33640702
[TBL] [Abstract][Full Text] [Related]
4. Pleomorphic giant cell adenocarcinoma of the prostate: report of 6 cases.
Parwani AV; Herawi M; Epstein JI
Am J Surg Pathol; 2006 Oct; 30(10):1254-9. PubMed ID: 17001156
[TBL] [Abstract][Full Text] [Related]
5. Gene fusion characterisation of rare aggressive prostate cancer variants-adenosquamous carcinoma, pleomorphic giant-cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases.
Alhamar M; Tudor Vladislav I; Smith SC; Gao Y; Cheng L; Favazza LA; Alani AM; Ittmann MM; Riddle ND; Whiteley LJ; Gupta NS; Carskadon S; Gomez-Gelvez JC; Chitale DA; Palanisamy N; Hes O; Trpkov K; Williamson SR
Histopathology; 2020 Dec; 77(6):890-899. PubMed ID: 32639612
[TBL] [Abstract][Full Text] [Related]
6. Pleomorphic giant cell carcinoma of the urinary bladder.
Lopez-Beltran A; Blanca A; Montironi R; Cheng L; Regueiro JC
Hum Pathol; 2009 Oct; 40(10):1461-6. PubMed ID: 19467692
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic features of lung pleomorphic (spindle/giant cell) carcinoma--a report of 17 cases].
Zhao ZL; Song N; Huang QY; Liu YP; Zhao HR
Ai Zheng; 2007 Feb; 26(2):183-8. PubMed ID: 17298750
[TBL] [Abstract][Full Text] [Related]
8. Pleomorphic giant cell carcinoma of the prostate.
Lopez-Beltran A; Eble JN; Bostwick DG
Arch Pathol Lab Med; 2005 May; 129(5):683-5. PubMed ID: 15859643
[TBL] [Abstract][Full Text] [Related]
9. Pleomorphic giant cell carcinoma of the urinary bladder: an extreme form of tumour de-differentiation.
Samaratunga H; Delahunt B; Egevad L; Adamson M; Hussey D; Malone G; Hoyle K; Nathan T; Kerle D; Ferguson P; Nacey JN
Histopathology; 2016 Mar; 68(4):533-40. PubMed ID: 26211928
[TBL] [Abstract][Full Text] [Related]
10. Sarcomatoid carcinoma of the prostate: a study of 42 cases.
Hansel DE; Epstein JI
Am J Surg Pathol; 2006 Oct; 30(10):1316-21. PubMed ID: 17001164
[TBL] [Abstract][Full Text] [Related]
11. Pleomorphic giant cell carcinoma of the prostate: A case report and mini‑review of the literature.
Fakhralddin SS; Ali RM; Abdullah AM; Faraj FM; Hussein DM; Mohammed SH; Abdalla BA; Kakamad FH; Rahim HM
Med Int (Lond); 2023; 3(6):60. PubMed ID: 38222251
[TBL] [Abstract][Full Text] [Related]
12. Polypoidal giant cancer cells in metastatic castration-resistant prostate cancer: observations from the Michigan Legacy Tissue Program.
Mannan R; Wang X; Bawa PS; Spratt DE; Wilson A; Jentzen J; Chinnaiyan AM; Reichert ZR; Mehra R
Med Oncol; 2020 Feb; 37(3):16. PubMed ID: 32030484
[TBL] [Abstract][Full Text] [Related]
13. DNA damage repair alterations are frequent in prostatic adenocarcinomas with focal pleomorphic giant-cell features.
Lotan TL; Kaur HB; Alharbi AM; Pritchard CC; Epstein JI
Histopathology; 2019 May; 74(6):836-843. PubMed ID: 30636012
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of urinary prostate cancer antigen-3 (PCA3) and TMPRSS2-ERG score changes when starting androgen-deprivation therapy with triptorelin 6-month formulation in patients with locally advanced and metastatic prostate cancer.
Martínez-Piñeiro L; Schalken JA; Cabri P; Maisonobe P; de la Taille A;
BJU Int; 2014 Oct; 114(4):608-16. PubMed ID: 24806330
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic Study of Gleason Pattern 5 Prostatic Adenocarcinoma With "Single-cell" Growth Reveals 2 Distinct Types, One With "Plasmacytoid" Features.
Nguyen JK; Chen YY; Magi-Galluzzi C; McKenney JK
Am J Surg Pathol; 2020 Dec; 44(12):1635-1642. PubMed ID: 32991340
[TBL] [Abstract][Full Text] [Related]
16. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
Wang W; Epstein JI
Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
[TBL] [Abstract][Full Text] [Related]
17. Poorly differentiated thyroid carcinoma with pleomorphic giant cells-a case report.
Gazeu A; Lopez J; Guyetant S; Sobrinho-Simoes M; Lifante JC; Cugnet-Anceau C; Decaussin-Petrucci M
Virchows Arch; 2020 Oct; 477(4):597-601. PubMed ID: 32239274
[TBL] [Abstract][Full Text] [Related]
18. Pleomorphic (spindle/giant cell) carcinoma of the lung. A clinicopathologic correlation of 78 cases.
Fishback NF; Travis WD; Moran CA; Guinee DG; McCarthy WF; Koss MN
Cancer; 1994 Jun; 73(12):2936-45. PubMed ID: 8199991
[TBL] [Abstract][Full Text] [Related]
19. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):664-73. PubMed ID: 11849788
[TBL] [Abstract][Full Text] [Related]
20. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]